CCL5 and pancreatic neoplasm: Thus, while support cells in the PDAC TME, such as myeloid cells and TAMs, can express CCL5 later on, pancreatic cancer cells’ ability and early expression of the chemokine lead to classifying it as produced by malignant epithelial cells.